GRI BIO ($GRI) posted quarterly earnings results for Q1 2026 on Wednesday, May 13th. The company reported earnings of -$1.61 per share, missing estimates of -$0.91 by $0.70. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $GRI stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
GRI BIO Hedge Fund Activity
We have seen 9 institutional investors add shares of GRI BIO stock to their portfolio, and 9 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DRW SECURITIES, LLC removed 100,612 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $695,269
- VANGUARD GROUP INC removed 16,393 shares (-96.4%) from their portfolio in Q4 2025, for an estimated $113,282
- GEODE CAPITAL MANAGEMENT, LLC removed 11,544 shares (-93.3%) from their portfolio in Q4 2025, for an estimated $79,773
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 9,052 shares (+3935.7%) to their portfolio in Q4 2025, for an estimated $62,552
- UBS GROUP AG added 8,722 shares (+inf%) to their portfolio in Q1 2026, for an estimated $19,973
- CRANBROOK WEALTH MANAGEMENT, LLC added 3,628 shares (+2707.5%) to their portfolio in Q1 2026, for an estimated $8,308
- TOWER RESEARCH CAPITAL LLC (TRC) removed 1,170 shares (-29.1%) from their portfolio in Q4 2025, for an estimated $8,085
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
GRI BIO Analyst Ratings
Wall Street analysts have issued reports on $GRI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Ascendiant Capital issued a "Buy" rating on 12/08/2025
To track analyst ratings and price targets for GRI BIO, check out Quiver Quantitative's $GRI forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
